Walleye Capital LLC - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.

Quarter-by-quarter ownership
Walleye Capital LLC ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$1,682,357
-75.6%
46,564
-74.9%
0.01%
-94.2%
Q1 2023$6,888,710
+261.1%
185,280
+340.1%
0.10%
+197.1%
Q4 2022$1,907,460
+763.1%
42,098
+1464.4%
0.04%
+483.3%
Q1 2022$221,000
-92.9%
2,691
-87.2%
0.01%
-93.8%
Q4 2021$3,095,000
+438.3%
21,096
+372.8%
0.10%
+159.5%
Q4 2019$575,000
-19.2%
4,462
-35.5%
0.04%
-52.6%
Q2 2019$712,000
-35.3%
6,920
-53.9%
0.08%
-56.9%
Q1 2019$1,100,00015,0000.18%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$136,602,67987.83%
EcoR1 Capital, LLC 5,748,399$250,400,2608.45%
Boxer Capital, LLC 3,201,440$139,454,7267.42%
RTW INVESTMENTS, LP 6,768,514$294,836,4706.22%
Paradigm Biocapital Advisors LP 1,668,116$72,663,1334.93%
Avoro Capital Advisors LLC 6,666,666$290,399,9714.53%
Octagon Capital Advisors LP 655,051$28,534,0224.38%
Artal Group S.A. 2,024,226$88,1753.78%
Ally Bridge Group (NY) LLC 70,283$3,061,5273.59%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 216,000$9,404,6403.17%
View complete list of MIRATI THERAPEUTICS INC shareholders